BE-61-OB65_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide, Angiogenesis Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Inhibitors of Signal Transduction Pathways targeting FLT4, KDR (Novartis, 6398883)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/6398883
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BE-61-OB65_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GAPDH glyceraldehyde-3-phosphate dehydrogenase 1.40571
TMSB10 thymosin beta 10 0.619559
RPS18 ribosomal protein S18 0.543722
UNCX UNC homeobox 0.496664
OAZ1 ornithine decarboxylase antizyme 1 0.316251
VPS4A vacuolar protein sorting 4 homolog A (S. cerevisiae) 0.3114
RPS28 ribosomal protein S28 0.277534
ZNF90 zinc finger protein 90 0.270035
PPIH peptidylprolyl isomerase H (cyclophilin H) 0.233189
TRAP1 TNF receptor-associated protein 1 0.207492

decreased expression

Symbol Name Standardized Value
RYK receptor-like tyrosine kinase -0.296107
TAF1C TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa -0.251263